ERBB2 and breast cancer: Tumors from the Trp53wm-R172H/+ mice were largely triple negative, whereas those from the Trp53wm-R245W/+ mice were triple negative, Her2 positive, and luminal B, faithfully phenocoping the association of different TP53 hot spot mutations with specific breast cancer subtypes in humans2.